Clinical Trial Update: Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of PNEUMOSTEM in premature infants with bronchopulmonary dysplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED